Skip to content

Effects of Health Education on Human Papilloma Virus Vaccine Uptake, Knowledge and Perception among Adolescent Secondary School Students in Cross River State, Nigeria

Effects of Health Education on Human Papilloma Virus Vaccine Uptake, Knowledge and Perception among Adolescent Secondary School Students in Cross River State, Nigeria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202410495674787
Enrollment
1024
Registered
2024-10-10
Start date
2024-08-30
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papilloma Virus

Interventions

Health Education and HPV vaccine
No intervention

Sponsors

Joseph Ajah Efut
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Adolescent secondary school students of Cross River State aged 10 – 19 years. • Adolescent secondary school students who are willing to participate in the study. • Adolescent secondary school students who are present at the time of data collection and intervention. • Adolescent secondary school students who are resident in Cross River State irrespective of place of birth.

Exclusion criteria

Exclusion criteria: • Adolescent secondary school students who are above 19years and less than 10years. • Adolescent secondary school students who are not resident in Cross River State. • Adolescent secondary school students who are between 10-19years but are not mentally stable. • Adolescent secondary school students who are in SS3 class will be excluded.

Design outcomes

Primary

MeasureTime frame
i.At least 90% of the study participants should know what HPV infection is and its risk factors. ii.At least 85% of the study participants should be able to identify signs and/or symptoms of HPV infection and its health implications. iii.At least 85% of the study participants should know about the preventive measures of HPV and have positive perception towards the uptake of the HPV vaccine.

Secondary

MeasureTime frame
iv. At least 90% of the study participants should know where to access the HPV vaccine close to their residential areas. v. At least 70% of the study participants should receive at least the first dose of the HPV vaccine within two months after the health education intervention.

Countries

Nigeria

Contacts

Public ContactBernadine Ekpenyong

Associate Professor Public Health Department University of Calabar

benyita2001@yahoo.com+2348033475138

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026